Stargardt Disease and Approaches to Learning for Individuals with This Condition

Autor/inn/en	Davis, Alexis Poe; Bullard-Maxwell, Amanda; Stone-Hernandez, Regina; Chiarolanzio, Emily; Griffin, Harold
Titel	Stargardt Disease and Approaches to Learning for Individuals with This Condition
Quelle	In: Journal of Visual Impairment & Blindness, 114 (2020) 4, S.325-331 (7 Seiten) PDF als Volltext Verfügbarkeit
Sprache	englisch
Dokumenttyp	gedruckt; online; Zeitschriftenaufsatz
ISSN	0145-482X
DOI	10.1177/0145482X20939470
Schlagwörter	Genetic Disorders; Visual Impairments; Clinical Diagnosis; Etiology; Intervention; Biomedicine; Cytology; Drug Therapy; Light; Special Needs Students; Accessibility (for Disabled); Assistive Technology; Braille; Electronic Publishing + Suchen Sie Ihr Suchwort? Visual handicap; Sehbehinderung; Ätiologie; Biomedizin; Zytologie; Licht; Sonderpädagogischer Förderbedarf; Accessibility; Zugänglichkeit; Elektronisches Publizieren
Abstract	Stargardt Disease was identified by German ophthalmologist Karl Stargardt in 1901. It is the most commonly inherited macular dystrophy condition (Light et al., 2017), with an estimated worldwide prevalence of 1 in 8,000 to 1 in 10,000 (Cai et al., 2018). Stargardt Disease is the juvenile version of macular degeneration (Daly, 2014), with its early form onset occurring at about 10 years of age and its standard onset being noted at 15 years of age (Lambertus et al., 2015). The condition affects both eyes and is usually diagnosed between the ages of 6 and 20 years (Stargardt Disease Defined, 2017). This practice report discusses possible causes and the diagnosis and prognosis of Stargardt Disease. (ERIC).
Anmerkungen	SAGE Publications. 2455 Teller Road, Thousand Oaks, CA 91320. Tel: 800-818-7243; Tel: 805-499-9774; Fax: 800-583-2665; e-mail: journals@sagepub.com; Web site: http://sagepub.com
Erfasst von	ERIC (Education Resources Information Center), Washington, DC
Update	2024/1/01